Outeiro TF - Search Results

1

β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease.

Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ; Registry investigators of the European Huntington's Disease Network. Vittori A, et al. Among authors: outeiro tf. J Huntingtons Dis. 2013;2(1):107-24. doi: 10.3233/JHD-130002. J Huntingtons Dis. 2013. PMID: 25057107

2

Yeast as a drug discovery platform in Huntington's and Parkinson's diseases.

Outeiro TF, Giorgini F. Outeiro TF, et al. Biotechnol J. 2006 Mar;1(3):258-69. doi: 10.1002/biot.200500043. Biotechnol J. 2006. PMID: 16897706 Review.

3

Yeast as a model for studying human neurodegenerative disorders.

Miller-Fleming L, Giorgini F, Outeiro TF. Miller-Fleming L, et al. Among authors: outeiro tf. Biotechnol J. 2008 Mar;3(3):325-38. doi: 10.1002/biot.200700217. Biotechnol J. 2008. PMID: 18228539 Review.

4

Current and future therapeutic strategies for Parkinson's disease.

Outeiro TF, Ferreira J. Outeiro TF, et al. Curr Pharm Des. 2009;15(34):3968-76. doi: 10.2174/138161209789649321. Curr Pharm Des. 2009. PMID: 19751203

5

The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative disease.

Amaral M, Outeiro TF, Scrutton NS, Giorgini F. Amaral M, et al. Among authors: outeiro tf. J Mol Med (Berl). 2013 Jun;91(6):705-13. doi: 10.1007/s00109-013-1046-9. Epub 2013 May 1. J Mol Med (Berl). 2013. PMID: 23636512 Review.

6

Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease.

Vittori A, Breda C, Repici M, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ; REGISTRY investigators of the European Huntington's Disease Network. Vittori A, et al. Among authors: outeiro tf. Hum Mol Genet. 2014 Jun 15;23(12):3129-37. doi: 10.1093/hmg/ddu022. Epub 2014 Jan 22. Hum Mol Genet. 2014. PMID: 24452335 Free PMC article.

7

β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease.

Vittori A, Orth M, Roos RA, Outeiro TF, Giorgini F, Hollox EJ; REGISTRY investigators of the European Huntington’s Disease Network. Vittori A, et al. Among authors: outeiro tf. J Huntingtons Dis. 2013 Mar 27;2(1):107-124. doi: 10.3233/JHD-130047. J Huntingtons Dis. 2013. PMID: 24587836 Free PMC article.

8

Glycation potentiates neurodegeneration in models of Huntington's disease.

Vicente Miranda H, Gomes MA, Branco-Santos J, Breda C, Lázaro DF, Lopes LV, Herrera F, Giorgini F, Outeiro TF. Vicente Miranda H, et al. Among authors: outeiro tf. Sci Rep. 2016 Nov 18;6:36798. doi: 10.1038/srep36798. Sci Rep. 2016. PMID: 27857176 Free PMC article.

9

Zebrafish as an Animal Model for Drug Discovery in Parkinson's Disease and Other Movement Disorders: A Systematic Review.

Vaz RL, Outeiro TF, Ferreira JJ. Vaz RL, et al. Among authors: outeiro tf. Front Neurol. 2018 Jun 1;9:347. doi: 10.3389/fneur.2018.00347. eCollection 2018. Front Neurol. 2018. PMID: 29910763 Free PMC article.

10

Glycation in Huntington's Disease: A Possible Modifier and Target for Intervention.

Brás IC, König A, Outeiro TF. Brás IC, et al. Among authors: outeiro tf. J Huntingtons Dis. 2019;8(3):245-256. doi: 10.3233/JHD-190366. J Huntingtons Dis. 2019. PMID: 31322580 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

354 results

Search Page

Filters